MoneyWorks4Me

Brooks Laboratories partners with SteriScience

17 Sep 2020 Evaluate

Brooks Laboratories has entered into joint venture partnership with SteriScience. The global marketing joint-venture arrangement, shall focus on international markets such as USA, Europe and other regulated markets. Simultaneously the joint venture partners have also entered into manufacturing joint venture towards building a robust carbapenem business with integrated manufacturing capabilities, subject to approval from the shareholders of Brooks. This is a landmark value-accretive partnership, which furthers Brooks' global aspirations.

Brooks Laboratories has wide range of products catering to critical care segment in Parental Section like Beta Lactam, Cephalosporin & General dry powder Injectables, Ampoules and Liquid vials.

Brooks Laboratories Share Price

59.50 0.17 (0.29%)
19-Aug-2026 14:11 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1892.50
Dr. Reddys Labs. 1169.30
Cipla 1418.10
Lupin 2221.50
Zydus Lifesciences 1108.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: